Anti-pyretic Effect of Modified Panchatikta Kashaya Varti In Wistar Albino Rats

 

Gayathri Sajeev, Vinay Kumar R Kadibagil, Sudhakar Bhat, Prakruthi TS, Anusha KR

1SDM College of Ayurveda and Hospital, B M Road, Thanniruhalla, Hassan - 573 201, Karnataka, India.

2SDM College of Ayurveda and Hospital, B M Road, Thanniruhalla, Hassan - 573 201, Karnataka, India.

3Research officer, SDM center Research in Ayurveda and Allied Sciences, Kuthpady, Udupi, Karnataka, India.

4SDM College of Ayurveda and Hospital, B M Road, Thanniruhalla, Hassan - 573 201, Karnataka, India.

5SDM College of Ayurveda and Hospital, B M Road, Thanniruhalla, Hassan - 573 201, Karnataka, India.

*Corresponding Author E-mail:

 

ABSTRACT:

Panchatikta Kashaya is a widely used formulation in clinical practice due to its efficacy in fever management. This study aimed to evaluate the Jwaraghna effect of Panchatikta Kashaya Varti in Wistar albino rats, following the Cakradatta Jwara Chikitsa reference. Since the Varti is a modified form of Panchatikta Kashaya, pre-clinical evaluation is essential before clinical trials to determine its efficacy. An experimental study on Wistar albino rats revealed that Panchatikta Kashaya Varti had a significant impact compared to standard and control groups. The drug's efficacy in reducing pyrexia is assessed by recording rectal temperatures in experimental animals. The modified form of Panchatikta Kashaya Varti is designed to bypass first-pass metabolism, enhancing absorption rates and bioavailability. Panchatikta Kashaya Varti demonstrated a quicker onset and sustained significant effectiveness over a longer duration, underscoring its potential therapeutic value. The study shows the potential therapeutic value of Panchatikta Kashaya Varti in a 1.9g prepared dose, suggesting its promising role as an anti-pyretic agent.

 

KEYWORDS: Panchatikta Kashaya, Modification, Varti, Wistar albino rats, Anti-pyretic effect.

 

 


INTRODUCTION:

It is essential to do animal experiments in the modern scientific period because they provide insight into diseases and drug action, also reveal the harmful effects of pharmaceuticals by observing how animals respond to them behaviorally. Before administering any medicine to human, drug screening in lower animals is necessary for the safety and efficacy. In order to understand the effect of drug on living organisms, isolated tissues, distributed cells, and also to give an insight into where and how the drugs acts several animal studies have been developed. Animal experiments include pharmacological study and toxicological study.

 

The objective of pharmacological study is to provide a scientific foundation for better therapeutics. Toxicity studies deal with the study of harmful effects of chemicals and the drugs on living organisms1.  

        

Panchatikta Kashaya is a widely used formulation in clinical practice, owing to its efficacy in fever management. This particular formulation is taken from Cakradatta Jwara Chikitsa2. The modified form of Panchatikta Kashaya Varti aims to bypass first-pass metabolism, thereby enhancing absorption rates and bioavailability. It also offers a solution for patients facing challenges with oral medication, such as those who are aged or children. The bitterness of Panchatikta Kashaya, from its five herbal components, can be overcome through the use of Varti dosage form.

 

The modified form of Panchatikta Kashaya as a Varti is taken here for the experimental study. The drug's efficacy in reducing pyrexia is assessed by recording rectal temperatures in experimental animals. The anti-pyretic effect is then compared with both a control group and a standard group. As this Kashaya helps in alleviating all types of Jwara, the modified form of Panchatikta Kashaya into a Guda Varti was taken up for the study. This research was undertaken due to the scarcity of studies related to the use of rectal suppositories in evaluating the Jwaraghna (fever-reducing) effect in Ayurveda.

 

OBJECTIVES:

Evaluation of anti-pyretic effect of Panchatikta Kashaya Varti in Wistar Albino rats.

 

MATERIALS AND METHODS:

Drug and Chemicals Used:

1.     Test drug : Panchatikta Kashaya Varti

2.     Standard drug: Paracetamol suppository

3.     Distilled water

4.     Brewer’s yeast solution

 

Equipment Used:

1.     Digital tele thermometer

2.     Glass beaker and stirrer

3.     Disposable syringes

4.     Weighing balance

5.     Hand gloves  

 

Experimental Animals:

Wistar strain albino rats were selected from animal house of SDM Center for Research in Ayurveda and Allied Science Udupi. The rats were maintained under strict laboratory conditions, controlled with environmental, temperature, humidity, and light dark cycles. Rats were fed with balanced pelleted diet commercially obtained from VRK nutritional solutions, Maharashtra and water ad libitum. The experimental protocol was approved by the institutional animal ethical committee.

 

Inclusion criteria:

a.     Healthy albino rats of either sex

b.     Weight of the rats will be within 300g

 

Exclusion criteria:

a.     Pregnant and diseased rats

b.     Less than 180 g and more than 300g

c.     Rats which are under trial of other experiments

 

Dose fixation:3,4

General dose of Varti explained in AFI is 12g, which was converted into rat dose by using the formula.

Animal dose (mg/kg) = Human Equalent dose × KM ratio

Km ratio = Average body weight ÷ Body surface area

Therefore, dosage of test drug Panchatiktaka Kashaya Varti is

=12×0.162

= 1.94 g

(To convert animal dose in mg/kg to HED in mg/kg, multiply the animal dose by 0.162)

Standard drug paracetamol suppository =175mg

Yeast injection dose: 1ml/100g body weight of rats.

 

The test drugs and standard drug were administered rectally, while the yeast suspension was injected subcutaneously. Animals were marked with saturated picric acid solution in water for proper identification. Within the cages, markings denoted areas such as Head (Rat1), Neck (Rat 2), Body (Rat 3), Tail Rat 4), Forelimb (Rat 5), and no mark (Rat 3). All the selected animals were kept under acclimatization for 7 days before dosing.

 

Table 1: Grouping of Wistar albino rats for experimentation

Group

Number of rats

Drug

Control

6

Standard diet and water

Test drug

6

Panchatikta Kashaya Varti

Standard drug

6

Paracetamol Suppository (Neomol- 175mg)

 

Preparation of brewer’s yeast 5

In a glass beaker, 6.250g of collected sample of brewer’s yeast was dissolved in 50ml of distilled water by constant stirring with a glass rod. This resulted in the preparation of a 12.5% yeast solution. The solution was then incubated at 37℃ for 48 hours for fermentation.

 

Procedure6

Eighteen Wistar albino rats were randomly divided into 3 groups, each containing 6 animals. All healthy rats selected for the experimental study underwent overnight fasting before the experiment. Initial normal rectal temperatures of all animals were recorded using a digital tele thermometer. Pyrexia was induced by administering 12.5% brewer’s yeast solution subcutaneously at a dose of 1ml/100mg of body weight to all rats, which were then placed in cages and kept overnight fasting. After 18 hours of brewer’s yeast injection, rectal temperatures of each rat were noted to confirm pyrexia. Only animals with a rectal temperature increase of 0.2 to 2℃ after yeast injection were included in the study. Corresponding standard and test drugs were administered to each group after 18 hours of yeast injection. Group 1 rats were administered distilled water as a control, group 2 received the Panchatikta Kashaya Varti (1.9g), and group 3 received paracetamol suppository at a dose of 175mg. After administering drugs to each group, rectal temperatures of each rat were recorded hourly for 5 hours and then again after 24 hours to obtain a sixth reading. The difference between the starting values and the obtained values was recorded. The maximum reduction in rectal temperature of the test drug was compared with the control group and the standard. The results were then analysed and compared. The data obtained was analysed by using one way analysis of variance (ANNOVA) followed by Dunnett multiple comparison T test as post hoc test for determination the level of significance of the observed effects. Graph Pad stat software was used for statistical analysis of the generated data.

 

The study was conducted after obtaining permission from the Institutional Animal Ethics Committee (IAEC) under approval number: SDMCRA /IAECISHR-10

 

Observations and results:

Initially normal body temperature of all rats was recorded. After the administration of Brewer’s yeast all the animals were observed for their behaviour changes. All the symptoms mentioned below confirmed that the rats are suffering from fever. The temperature of all albino rats increased, and trembling was noted after one hour of Brewer’s yeast injection. Additionally, their fur was erected, and the faces of all the animals were bent down. They were also not very active.

 

Observations and results of the study to evaluate the antipyretic activity of Panchatikta Kashaya Varti are presented in the following tables 2 to5.

 

Data showed that there was an increase in rectal temperature of control group at 1,2,3,4,5th and 24th hours compared to basal rectal temperature of the same group. The standard drug (paracetamol) administered group has shown significant reduction in rectal temperature measured during 3,4 hour and non-significant in 1st,2nd,5th ,24th hours after drug administration. The observed changes were not statistically significant while compared to initial rectal temperature after Brewer’s yeast injection.

 

The test drug Panchatikta Kashaya Varti administered group has shown significant reduction in rectal temperature measured during 1,2,3,4,5th hours after drug administration and non- significant in 24th hr. But the rectal temperature measured during 1,2,3,4,5, and 24th hr. was found to be decreased while compared to initial rectal temperature after brewer’s yeast injection.

 


 

Table 2: The comparison of temperature (℃) from initial temperature to 24th hour (control group)

Rat identification

Weight

(gm)

Basal temperature

Yeast dose

Temperature after 18hrs

1st hr

2nd hr

3rd hr

4th hr

5th hr

24th hr

Head (Rat 1)

286

38.2

2.8ml

38.5

39.4

39.5

39.6

39.6

40.0

38.9

Neck (Rat 2)

264

38.2

2.6ml

38.8

40.4

39.1

39.7

40.1

39.9

39.2

Body (Rat 3)

274

38.2

2.7ml

38.5

39.2

38.9

39.6

40

39.3

38.9

Tail (Rat 4)

266

36.2

2.6ml

38.5

39.3

39.4

38.9

39.9

39.9

40.6

Forelimb (Rat 5)

237

38.6

2.3ml

38.7

38.9

39.4

38.8

40.0

40.2

38.7

Normal (Rat 6)

273

38.5

2.7ml

38.8

39.3

39.3

39.6

40.0

38.1

39.4

 

Table 3: The comparison of temperature (℃) from initial temperature to 24th hour (Standard group)

Rat identification

Weight

(gm)

Basal temperature

Yeast dose

Temperature after 18hrs

1st hr

2nd hr

3rd hr

4th hr

5th hr

24th hr

Head (Rat 1)

210

38.5

2.1ml

39

38.9

38.8

37.7

40.7

-

-

Neck (Rat 2)

198

38.1

1.9ml

39.2

38.2

37.3

37.7

38.4

38.3

-

Body (Rat 3)

210

38.1

2.1ml

39.9

39.1

39.0

38.1

38.7

39.1

39.1

Tail (Rat 4)

209

38.2

2.0ml

39.6

40.3

39.6

39.4

39.6

39.6

39.8

Forelimb (Rat 5)

233

38.8

2.3ml

39.5

38.9

38.3

38.1

39.0

38.6

40.4

Normal (Rat 6)

228

38.6

2.2ml

39.6

39.6

39.0

39

39.6

39.4

39.1

 

Table 4: The comparison of temperature (℃) from initial temperature to 24th hour (Test group)

Rat identification

Weight

(gm)

Basal temperature

Yeast dose

Temperature after 18hrs

1st hr

2nd hr

3rd hr

4th hr

5th hr

24th hr

Head (Rat 1)

240

38.4

2.4ml

39.2

38.7

37.9

38.0

38.9

39.1

39.0

Neck (Rat 2)

220

38.0

2.2ml

40.3

39.1

38.8

38.6

39.0

38.6

38.3

Body (Rat 3)

255

38.1

2.5ml

39.5

39.0

38.9

38.5

38.3

38.7

39.3

Tail (Rat 4)

207

38.6

2.0ml

39.6

37.9

37.6

37.6

38.0

38.0

38.0

Forelimb (Rat 5)

218

38.3

2.1ml

40.1

37.7

37.1

37.0

37.4

37.0

36.1

Normal (Rat 6)

212

38.8

2.1ml

39.6

38.3

37.7

37.1

37.1

-

-

 

Table 5: Effect of test group, standard and control group in wistar albino rats within the groups

Group

Rectal temperature measured at the different time intervals (℃)

1st

2nd

3rd

4th

5th

24th

Control

39.41±0.20

39.26±0.09

39.36±0.16

39.93±0.07

39.56±0.77

39.28±0.28

Standard

39.22±0.35

38.64±0.39

38.46±0.31*

39.06±0.24*

39±0.54

39.6±0.31

Test drug

38.45±0.23*

38±0.28**

37.8±0.27**

38.11±0.31**

38.28±0.81*

38.14±0.56

Data expressed in Mean ±SEM, *P<0.05, **P<0.01 in comparison to rectal temperature (℃) 18 hrs after yeast induced pyrexia.

 


Table 6: Effect of Panchatikta Kashaya Varti on 1st hour of temperature

Group

1st hour

% changes

Control

39.41±0.20

-

Paracetamol

39.22 ±0.35

0.48↓

Panchatikta Kashaya Varti

38.45±0.23*

2.43↓

Data: Mean ±SEM, *P<0.05, **P<0.01

 

The data shows there was decrease in body temperature after 1 hr. of standard, when compared to the control group, the observed decrease was found to be statistically non-significant 

 

The data shows there was decrease in body temperature after 1 hr. of Panchatikta Kashaya Varti when compared to the control group, the observed decrease was found to be statistically significant 

 

Table 7: Effect of Panchatikta Kashaya Varti on 2nd hour of temperature

Group

2nd hour

% changes

Control

39.26±0.09

-

Paracetamol

38.64 ±0.39

1.57↓

Panchatikta Kashaya Varti

38±0.28**

3.20↓

Data: Mean ±SEM, *P<0.05, **P<0.01

 

During 2nd hr. the data shows there was decrease in body temperature when Panchatikta Kashaya Varti administered compared to the control group, the observed decrease was found to be statistically very significant. where standard drug showed non-significant results compared to control group.

 

Table 8: Effect of Panchatikta Kashaya Varti on 3rd hour of temperature

Group

3rd hour

% changes

Control

39.36±0.16

-

Paracetamol

38.46 ±0.31*

2.28↓

Panchatikta Kashaya Varti

37.8±0.27**

3.96↓

Data: Mean ±SEM, *P<0.05, **P<0.01

 

The data shows there was decrease in body temperature after 3rd hr. of standard, when compared to the control group, the observed decrease was found to be statistically significant 

 

The data shows there was decrease in body temperature after 3rd hr. of Panchatikta Kashaya Varti, when compared to the control group, the observed decrease was found to be statistically very significant.

 

Table 9: Effect of Panchatikta Kashaya Varti on 4th hour of temperature

Group

4th hour

% changes

Control

39.93±0.07

-

Paracetamol

39.06 ±0.24*

2.17↓

Panchatikta Kashaya Varti

38.11±0.31**

4.55↓

Data: Mean ±SEM, *P<0.05, **P<0.01

The data shows there was decrease in body temperature after 4th hr. of standard, when compared to the control group, the observed decrease was found to be statistically significant 

 

The data shows there was decrease in body temperature after 4th hr. of Panchatikta Kashaya Varti, when compared to the control group, the observed decrease was found to be statistically very significant 

 

Table 10: Effect of Panchatikta Kashaya Varti on 5th hour of temperature

Group

5th hour

% changes

Control

39.56±0.77

-

Paracetamol

39±0.54

1.41↓

Panchatikta Kashaya Varti

38.28±0.81*

3.23↓

Data: Mean ±SEM, *P<0.05, **P<0.01

 

The data shows there was decrease in body temperature after 5th hr. of standard, when compared to the control group, the observed decrease was found to be statistically non-significant. 

 

The data shows there was decrease in body temperature after 5th hr. of Panchatikta Kashaya Varti, when compared to the control group, the observed decrease was found to be statistically significant.

 

Table 11: Effect of Panchatikta Kashaya Varti on 24th hour of temperature

Group

24th hour

% changes

Control

39.28±0.28

-

Paracetamol

39.14±0.31

0.81↓

Panchatikta Kashaya Varti

38.14±0.56

2.90↓

Data: Mean ±SEM, *P<0.05, **P<0.01

 

The data shows there was decrease in body temperature after 24th hr. of standard, when compared to the control group, the observed decrease was found to be statistically non-significant 

 

The data shows there was decrease in body temperature after 24th hr. of Panchatikta Kashaya Varti, when compared to the control group, the observed decrease was found to be statistically non- significant

 

Statistical Analysis:

The experimental data were expressed as Mean± SEM (Standard Error of Mean). The data obtained was analysed by using one way analysis of variance (ANOVA) followed by Dunnett multiple comparison T test as post hoc test for determination the level of significance of the observed effects. A ‘P’ value of less than 0.05 was considered statistically significant.

 


Table 12: Statistical Analysis of Groups

Group

1sthr. temp

2ndhr.temp

3rdhr.temp

4thhr.temp

5thhr.temp

24thhr.temp

Paracetamol

NS D

NS D

SD

SD

NS D

NS D

Panchatikta Kashaya Varti

SD

SD

SD

SD

SD

NS D

SD – Significant Decrease

NS D – Non-Significant Decrease

 


DISCUSSION:

As the Varti is a modified form of Panchatikta Kashaya, pre-clinical evaluation is necessary before clinical trials to assess its efficacy. Therefore, the primary focus of this study was to evaluate the antipyretic effect of the Varti derived from Panchatikta Kashaya.

 

In this study, pyrexia was induced using a 12.5% Brewer’s yeast solution which is commonly employed in experiments involving rat’s model. As the normal rectal temperature of rat model is 37.5-38.5℃ Rats exhibiting rectal temperatures above 38.5℃ were selected for the study. There after the effectiveness of Paracetamol and Panchatikta Kashaya Varti was compared over a 24-hour period, temperature changes were monitored at six different time intervals; the 1st hour, 2nd hour, 3rd hour, 4th hour, 5th hour, and 24th hour.

 

For the Paracetamol group, no significant difference (NSD) in temperature was observed during the 1st, 2nd, and 24th hours, indicating a slower onset of action. However, a significant difference (SD) was recorded at the 3rd and 4th hours, suggesting that its peak effectiveness occurs slightly later. The 5th-hour measurement also showed no significant difference (NSD). This indicates that while Paracetamol is slower to start, it reaches peak effectiveness in the mid-term (3rd and 4th hours) but loses its significant effect by the 5th hour.

 

In contrast, the Panchatikta Kashaya Varti group Showed significant temperature reduction from the 1st hour itself, indicating a quicker onset of action. Maintained significant temperature reduction consistently through the 1st to 5th hours, also suggesting sustained effectiveness during this period. However, by the 24th hour, no significant difference (NS D) was observed.

 

By the 24th hour, both treatments showed no significant difference in temperature, indicating that the effects of each drug were reduced over time and may not last a full 24 hours.

 

Brewer’s yeast is a fungus that contains lipopolysaccharide, a cell wall component of gram-negative bacteria. This component binds with macrophages and releases cytokines and interleukin-1 into the blood circulation, triggering an antigen-antibody reaction. It then crosses the blood-brain barrier and releases arachidonic acid, mediated by the enzyme’s phospholipase, prostaglandin E2 synthase, and cyclooxygenase. Ultimately, the synthesis and release of prostaglandin E2 (pgE2) into the anterior hypothalamus result in pyrexia7.

 

Panchatikta Kashaya Varti was administered rectally to enhance absorption and bioavailability by bypassing first-pass metabolism. This route avoids digestive enzymes and stomach acidity that may degrade medications. It also reduces gastrointestinal side effects like nausea and minimizes systemic side effects too. The rectum's rich blood supply ensures rapid systemic absorption, making it ideal for patients who struggle with oral medication. Panchatikta Kashaya is unpalatable due to the bitterness of its five ingredients. Administering it rectally resolves this issue. This method is effective for patients with vomiting, gastrointestinal issues, unconsciousness, swallowing difficulties, or uncooperativeness, such as young children or the elderly. As the ingredients of Panchatikta Kashaya Varti primarily possess Tikta Rasa, they help effectively manage fever and its associated symptoms.

 

In research studies, gingerol and shogaols, the two most active constituents of ginger-based preparations, have shown anti-pyretic, anti-emetic, analgesic, and anti-inflammatory activities.8 The base of the Varti used was cocoa butter, chosen for its ability to readily melt at body temperature, facilitating the rapid release and absorption of the medicine9,10.

 

CONCLUSION:

In this study, an attempt was made to assess the Jwaraghna effect of Panchatikta Kashaya Varti in Wistar albino rats prepared according to Cakradatta Jwara Chikitsa reference. As the Varti is a modified form of Panchatikta Kashaya, pre-clinical evaluation is necessary before clinical trials to assess its efficacy. To know the effect of Panchatikta Kashaya Varti experimental study was conducted in wistar albino rats which shows significant effect compared with standard and control group. While comparing, Panchatikta Kashaya Varti showed faster onset and maintains significant effectiveness for a longer period which shows the potential therapeutic value of Panchatikta Kashaya Varti in a 1.9g and 5cm in length  prepared dose, suggesting its promising role as an antipyretic formulation.


 

 

 

 

Brewer’s yeast

Marking of animals

Test animals

 

 

 

Weight checking

Food pellets

Measured water

 

 

 

Test drug

Subcutaneous administration of yeast

Insertion of standard drug

 

 

 

Insertion of test drug

Digital tele thermometer

Basal rectal temperature

 

Fig. 1: Pictures showing steps of experimental study

 


 

REFERENCES:

1.      A Tamil Selvan, R Suresh, N Siva Subramanian, M Rama Devi. Evaluation of Acute and Subacute Toxicity Studies of Polyherbal Extract on Rodents. Research. Journal of Pharmacology and Pharmacodynamics. 2014; 6(2): 94-100.

2.      Sharma PV. Cakradatta. A treatise on principles and practices of Ayurvedic medicine. Chaukhambha Orientalia, Varanasi. 1994: 132; p.20.

3.      Jacob S, Nair AB, Morsy MA. Dose Conversion Between Animals and Humans: A Practical Solution. Indian Journal of Pharmaceutical Education and Research. 2022; 56(3): 600-7.

4.      Nair A, Morsy MA, Jacob S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug Dev Res. 2018; 79(8): 373-82. Doi: 10.1002/ddr.21461, PMID 30343496

5.      A. Elumalai, M. Chinna Eswaraiah, Karisha Madhavi Lahari, Hamed Ali Shaik. In-vivo screening of Bougainvillea glabra leaves for its Analgesic, Anti-pyretic and Anti-inflammatory activities. Asian J. Res. Pharm. Sci. 2012; 2(3): 85-87.

6.      Gosh M N. Fundamental of experimental pharmacology 2nd ed. Kolkata: Scientific book Agency; 1984.p4.

7.      Singh SG, Nishteswar K, Patel BR, Nariya M. Comparative antipyretic and analgesic activities of Cissampelos pareira Linn. and Cyclea peltata (Lam.) Hook. F. and Thomas. Ayu. 2016; 37(1): 62-66. doi: 10.4103/ayu.AYU_208_14. PMID: 28827957; PMCID: PMC5541469.

8.      Pranay Wal, Nikita Saraswat, Rashmi Saxena Pal, Ankita Wal, Sonali Dubey. A Detailed Review on Traditionally used and potent sources showing Anti-pyretic action. Research J. Pharm. and Tech. 2019; 12(10): 5107-5112. Doi: 10.5958/0974-360X.2019.00885.0

9.      V. M. Chushenko, T. G. Yarnykh, G. B. Yuryeva, I. V. Herasymova. Creation of Cocoa butter bases for preparation of suppositories in pharmacy condition by the casting method. Research J. Pharm. and Tech. 2020; 13(7): 3343-3346

10.   Ibtihal Abdulkadhim Dakhil, Masar Basim Mohsin Mohamed, Ali Khidher Abbas, Saja Mohammed Mansour. Formulation and Evaluation of Trifluoperazine HCl as rectal suppositories by using different types of surfactants in Cocoa butter. Research J. Pharm. and Tech. 2019; 12(10): 4934-4940. Doi: 10.5958/0974-360X.2019.00856.4

 

 

 

 

Received on 11.07.2024      Revised on 16.06.2025

Accepted on 04.01.2026      Published on 10.02.2026

Available online from February 16, 2026

Research J. Pharmacy and Technology. 2026;19(2):692-698.

DOI: 10.52711/0974-360X.2026.00101

© RJPT All right reserved

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.